Many countries found Maggi noodles to be safe for consumption.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
Test reports from UP food regulator started the controversy.
These vaccines have not yet been approved by the World Health Organization
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
The under-one-minute films are titled 'Menu Cards, Mom and Neighbours'.
'In the likelihood that Omicron is circulating, you have a much greater chance of getting infected now, than you did during the Age of Delta.'
South-east Asian countries are emerging as preferable destination for India's pharma companies to expand their business as they share similar patient population and disease profile and moreover, have a conducive environment for their operations like easy market approach without any regulatory uncertainty, the survey of Indian pharma firms highlighted.
The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.
The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.
To focus on molecules at advanced stage of development; move to impact 200 scientists.
Thailand expressed interest in the Indian defence industry and its experience and expertise in the field of defence R&D and production. Modi welcomed Thai investments in India in the potential areas under the 'Make in India' initiative, especially in the manufacturing sector, infrastructure development, tourism and hospitality facilities.
'The Centre and state need to take a unified approach and take concerted action before this matter assumes menacing proportions because unemployment, the drug trade and the levels of frustration among the youth make them vulnerable to any maverick who promises something better.'
4 Ranbaxy facilities in India have been barred from exporting to US.
The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.
Of the 30-share Sensex pack, 22 ended with losses while NTPC ended flat at Rs 127.30.
Maggi re-entered the market on November 9.
Instant noodle from Nestle is not the first food brand in India to have faced a tough time though
Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.
Upset over the Devyani Khobragade episode, India on Wednesday raised with the United States its concerns over "trafficking" visas issued to family members of Sangita Richard, the absconding maid of the Indian diplomat whose arrest had triggered a row between the two countries.
Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.
Asset valuation consultancy sees brand value slip to $2.2 billion.
The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.
'Nobody is attacking the company or the vaccine.' 'The concerns are about the process and the lack of transparency.'
Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.
CBD oil, found in marijuana, is gaining popularity for its pain-relieving properties. It's now legally available in India
The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.
The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general
Vice President Mike Pence said Trump had authorised a ban on entry of foreign nationals who travelled to Iran in the last 14 days. The United States also advised its citizens not to travel to parts of South Korea and Italy, from where reports of coronavirus have appeared.
As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.
The Indian Council of Medical Research will start national-level sero surveys to assess the spread of Covid-19 and all states/Union territories should also be encouraged to conduct them so that information from all geographies can be collected, the Union health ministry said on Friday.
Sun Pharma's offer was tempting because Ranbaxy was too busy fighting fires in the US to concentrate on operations.
Experts question Nestle's silence over Maggi controversy.
'Rolling out the vaccine is not a major challenge in India.'
The matter is now expected to be raised with the PMO.